Skip to content

Full Plate Living Nutrition Education Program

Full Plate Living Nutrition Education Program

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07271940
Enrollment
42
Registered
2025-12-09
Start date
2026-01-12
Completion date
2027-01-01
Last updated
2026-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Obesity, Pre Diabetes

Keywords

fiber, nutrition

Brief summary

The purpose of the research is to evaluate the acceptability and feasibility of implementing a 8-session nutritional education program in a general internal medicine clinic. This program emphasizes a fiber-rich, whole foods diet consisting of fruits, vegetables, legumes, whole grains, nuts and seeds. Such interventions can improve diabetes management and lead to weight loss. 48 participants will be enrolled and on study for approximately 5 months.

Interventions

OTHERFull Plate Living Nutrition Education Program

Participants will attend 8 sessions over 8 weeks. Participants will learn about the importance of fiber and how to add fiber to their diet.

Sponsors

University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
22 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Pre-diabetes or diabetes * Body Mass Index (BMI) 30-42 * UW Health Primary Care Physician

Exclusion criteria

* Pregnant * Active cancer (treatment within one year or planning on having treatment) * Eating Disorder (SDE Screening 2+) * Chronic Kidney Disease (CKD) (Stage 4 or 5) * Patient Health Questionnaire-9 (PHQ9) indicating severe depression (greater than 15) * No PHQ9 and PHQ2 greater than 2 * General Anxiety Disorder-7 (GAD7) indicating severe anxiety (greater than 15) * No GAD 7 and GAD2 greater than 2 * Inflammatory bowel disease (IBD) * Irritable bowel syndrome (IBS) * Readiness to Change less than 7 * Confidence to Change less than 7 * Lack of transportation * Non-English Speaking * No control over food environment * No access to laptop, desktop computer, or tablet * No email or text message access * Unwilling to participate in a shared medical visit * Unable to attend one of the four concurrent shared medical visit session cohorts * For those on insulin, no access to finger-prick blood glucose meter or continuous glucose monitor

Design outcomes

Primary

MeasureTime frame
Participant Weightretrospectively from 2 years prior to enrollment and up to 20 weeks on study (3 month follow up)

Secondary

MeasureTime frameDescription
Automated Self-Administered 24-Hour Dietary Assessment Tool (ASA24)baseline, 8 weeks, 20 weeks (3 month follow up)Dietary fiber (grams per day) will be measured using the Automated Self-Administered 24-Hour Dietary Assessment Tool (ASA24) which has been validated for measuring fiber intake in adults. The ASA24 is a free, web-based tool. Participants will complete the ASA24 online two times prior to the first session, 2 times prior to the last session, and 2 times 3 months after the last session.
Participant Quality of Life measured by the SF-12 scorebaseline, 8 weeks, 20 weeks (3 month follow up)Possible scores range from 0-100 with higher scores indicating better quality of life.
Acceptability: Percent of Participants who found the intervention acceptableParticipant surveyed at the end of last session, approximately 8 weeksA subset of participants will be invited to complete an individual interview after the last session. The aim is to schedule 8-12 participants for interviews including both participants who completed all the sessions and those stopped attending sessions. Data will be derived from these qualitative semi-structured interviews.
Feasibility: Participant Retention Ratebaseline, 8 weeks, 20 weeks (3 month follow up)Feasibility will in part be measured by participant retention rate, the number of participants who complete each time point of data collection over the number of participants enrolled.
Feasibility: Participation RateThrough enrollment (up to 3 months)Feasibility will in part be measured by participation rate, the number of participants enrolled over the target enrollment.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORKatie Miller, MD

UW School of Medicine and Public Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 17, 2026